Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,780 | -20,150 | -25,780 | -2,240 | 660 |
| Depreciation Amortization | 7,450 | 6,740 | 2,420 | 1,190 | 970 |
| Other Working Capital | -9,180 | -1,800 | -3,630 | -1,500 | 1,400 |
| Other Operating Activity | 17,140 | 4,840 | 5,100 | -7,660 | -7,170 |
| Operating Cash Flow | $10,630 | $-10,370 | $-21,890 | $-10,210 | $-4,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,760 | -850 | -5,140 | -390 | -660 |
| Net Acquisitions | -41,170 | -13,510 | -43,900 | -8,700 | -1,380 |
| Other Investing Activity | 9,410 | 18,930 | -28,340 | 12,240 | -6,230 |
| Investing Cash Flow | $-33,520 | $4,570 | $-77,380 | $3,150 | $-8,270 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 28,100 | 12,820 | 99,250 | 9,610 | 13,250 |
| Financing Cash Flow | $28,100 | $12,820 | $99,250 | $9,610 | $13,250 |
| Exchange Rate Effect | -130 | 70 | 520 | 490 | 0 |
| Beginning Cash Position | 18,620 | 8,940 | 11,990 | 4,690 | 4,050 |
| End Cash Position | 23,700 | 16,040 | 12,490 | 7,740 | 4,880 |
| Net Cash Flow | $5,080 | $7,100 | $500 | $3,050 | $830 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,630 | -10,370 | -21,890 | -10,210 | -4,140 |
| Free Cash Flow | 10,630 | -10,370 | -21,890 | -10,210 | -4,140 |